European Pharmacovigilance & Clinical Trials 2016 is a conference dedicated to the key issues, various developments, challenges and innovations in the field of Pharacovigilance and Clinical Trials.
European Pharmacovigilance & Clinical Trials 2016 covers topics such as:
- PV regulations and challenges
- Harmonization and Pharmacovigilance
- Risk management and minimization
- The new EU legislation on clinical trials, its impact and future
- Signal detection and post authorization safety
- Adverse drug reactions reporting
- Clinical data management
- Business development and models in clinical trials
- IT and new technologies for improvement of PV and clinical research
- Good Clinical Practices and Good Pharmacovigilance practices
- Strategies to improve clinical trials and PV
European Pharmacovigilance & Clinical Trials 2016 brings together attendees involved or interested in:
- Directors
- VPs
- CEO`s
- Heads
- CIO`s
- CTO`s
- Vice Presidents
- Presidents
- Heads & Managers
- Directors
- Consultants and professionals in the following Healthcare policy makers Healthcare practitioners Pharmaceutical industry scientists
- Scientific Advisors
- Executives Executives and scientists from clinical research organizations Contract outsourcing service providers IT consultants
- Researchers
